Circadian Rhythm-related Genes Index: A Predictor for HNSCC Prognosis, Immunotherapy Efficacy, and Chemosensitivity

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Mar 27

PMID 36969232

Authors

Hao Chi

Jinyan Yang

Gaoge Peng

Jinhao Zhang

Guobin Song

Xixi Xie

Zhijia Xia

Jinhui Liu

Gang Tian

Affiliations

Soon will be listed here.

Abstract

Background: Head and neck squamous cell carcinoma (HNSCC) is the most common head and neck cancer and is highly aggressive and heterogeneous, leading to variable prognosis and immunotherapy outcomes. Circadian rhythm alterations in tumourigenesis are of equal importance to genetic factors and several biologic clock genes are considered to be prognostic biomarkers for various cancers. The aim of this study was to establish reliable markers based on biologic clock genes, thus providing a new perspective for assessing immunotherapy response and prognosis in patients with HNSCC.

Methods: We used 502 HNSCC samples and 44 normal samples from the TCGA-HNSCC dataset as the training set. 97 samples from GSE41613 were used as an external validation set. Prognostic characteristics of circadian rhythm-related genes (CRRGs) were established by Lasso, random forest and stepwise multifactorial Cox. Multivariate analysis revealed that CRRGs characteristics were independent predictors of HNSCC, with patients in the high-risk group having a worse prognosis than those in the low-risk group. The relevance of CRRGs to the immune microenvironment and immunotherapy was assessed by an integrated algorithm.

Results: 6-CRRGs were considered to be strongly associated with HNSCC prognosis and a good predictor of HNSCC. The riskscore established by the 6-CRRG was found to be an independent prognostic factor for HNSCC in multifactorial analysis, with patients in the low-risk group having a higher overall survival (OS) than the high-risk group. Nomogram prediction maps constructed from clinical characteristics and riskscore had good prognostic power. Patients in the low-risk group had higher levels of immune infiltration and immune checkpoint expression and were more likely to benefit from immunotherapy.

Conclusion: 6-CRRGs play a key predictive role for the prognosis of HNSCC patients and can guide physicians in selecting potential responders to prioritise immunotherapy, which could facilitate further research in precision immuno-oncology.

Citing Articles

Transcriptome profiling revealed multiple circadian rhythm-related genes associated with common gynecological cancers.

Peng L, Jiang M, Li K, Yu S, Zhao C, Zhang L Front Oncol. 2025; 15:1422122.

PMID: 39944833 PMC: 11813765. DOI: 10.3389/fonc.2025.1422122.

Exploring potential biomarkers for acute myocardial infarction by combining circadian rhythm gene expression and immune cell infiltration.

Yu X, Zhang X, Bilal H, Shi C, Sun L Sci Rep. 2025; 15(1):4012.

PMID: 39893248 PMC: 11787365. DOI: 10.1038/s41598-025-88568-2.

SPHK1 promotes HNSCC immune evasion by regulating the MMP1-PD-L1 axis.

Fang Q, Chen X, Cao F, Xu P, Zhao Z, Lin R Theranostics. 2024; 14(18):7199-7218.

PMID: 39629135 PMC: 11610131. DOI: 10.7150/thno.102390.

Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.

Zhang C, Yin W, Yuan L, Xiao L, Yu J, Xiao W Sci Rep. 2024; 14(1):25426.

PMID: 39455662 PMC: 11511820. DOI: 10.1038/s41598-024-76565-w.

Construction of a prognostic model via WGCNA combined with the LASSO algorithm for stomach adenocarcinoma patients.

Huang Z, Ran W, Wang G Front Genet. 2024; 15:1418818.

PMID: 39170694 PMC: 11335515. DOI: 10.3389/fgene.2024.1418818.

References

Zhang H, Li R, Cao Y, Gu Y, Lin C, Liu X . Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Ann Surg. 2020; 275(4):e626-e635. DOI: 10.1097/SLA.0000000000004037. View

Huang C, Liang Y, Dong Y, Huang L, Li A, Du R . Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. Front Cell Dev Biol. 2022; 10:884590. PMC: 9445128. DOI: 10.3389/fcell.2022.884590. View

Elliott L, Doherty G, Sheahan K, Ryan E . Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity. Front Immunol. 2017; 8:86. PMC: 5292650. DOI: 10.3389/fimmu.2017.00086. View

Morris L, Kaufman A, Gong Y, Ramaswami D, Walsh L, Turcan S . Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet. 2013; 45(3):253-61. PMC: 3729040. DOI: 10.1038/ng.2538. View

Qi X, Jia B, Zhao X, Yu D . Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma. Onco Targets Ther. 2017; 10:5745-5754. PMC: 5716310. DOI: 10.2147/OTT.S148182. View

Li H . The role of circadian clock genes in tumors. Onco Targets Ther. 2019; 12:3645-3660. PMC: 6526167. DOI: 10.2147/OTT.S203144. View

Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R . Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014; 13(20):3282-91. PMC: 4613905. DOI: 10.4161/15384101.2014.954454. View

Racle J, de Jonge K, Baumgaertner P, Speiser D, Gfeller D . Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017; 6. PMC: 5718706. DOI: 10.7554/eLife.26476. View

Mariathasan S, Turley S, Nickles D, Castiglioni A, Yuen K, Wang Y . TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018; 554(7693):544-548. PMC: 6028240. DOI: 10.1038/nature25501. View

10.

Peng G, Chi H, Gao X, Zhang J, Song G, Xie X . Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes. Front Genet. 2022; 13:1010044. PMC: 9672384. DOI: 10.3389/fgene.2022.1010044. View

11.

Lanner J, Georgiou D, Joshi A, Hamilton S . Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol. 2010; 2(11):a003996. PMC: 2964179. DOI: 10.1101/cshperspect.a003996. View

12.

Narasimamurthy R, Hatori M, Nayak S, Liu F, Panda S, Verma I . Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A. 2012; 109(31):12662-7. PMC: 3411996. DOI: 10.1073/pnas.1209965109. View

13.

Hoskin D, Mader J, Furlong S, Conrad D, Blay J . Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol. 2008; 32(3):527-35. View

14.

Sancar A . Regulation of the mammalian circadian clock by cryptochrome. J Biol Chem. 2004; 279(33):34079-82. DOI: 10.1074/jbc.R400016200. View

15.

Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

16.

. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

17.

Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

18.

Chi H, Peng G, Wang R, Yang F, Xie X, Zhang J . Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients. Cells. 2022; 11(21). PMC: 9658590. DOI: 10.3390/cells11213436. View

19.

Zhao S, Chi H, Ji W, He Q, Lai G, Peng G . A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas. Brain Sci. 2022; 12(10). PMC: 9599312. DOI: 10.3390/brainsci12101349. View

20.

Jayaraman P, Parikh F, Newton J, Hanoteau A, Rivas C, Krupar R . TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy. Oncoimmunology. 2018; 7(10):e1490853. PMC: 6169570. DOI: 10.1080/2162402X.2018.1490853. View